For Igneus, sustained customer trust is built through consistent product quality, technical understanding and dependable service
Abhishek Shrotriya, Founder
The pharmaceutical and life sciences industries depend on precision, consistency and uninterrupted laboratory operations. As research becomes increasingly sophisticated and pharmaceutical manufacturers adopt advanced technologies, the role of laboratory equipment suppliers has expanded beyond product distribution. Laboratories today require dependable instruments, quality-assured consumables, efficient procurement and technical support to maintain productivity. However, inconsistent product quality, limited availability and prolonged import timelines continue to create operational challenges.
Addressing these requirements is Igneus Life Science, a Mumbai-based supplier of laboratory equipment, scientific consumables and cold storage solutions. Established in 2019, the company has positioned itself as a solution-oriented partner for pharmaceutical, biotechnology, diagnostic and research laboratories. By combining a diversified product portfolio with technical consultation and inventory readiness, Igneus helps customers simplify procurement and maintain operational continuity.
Leading the company is Founder Abhishek Shrotriya, who established Igneus after recognising gaps in the product portfolios of existing suppliers. His vision was to create a dependable source for scientific products while eliminating the inconvenience of dealing with multiple vendors. Under his leadership, the company has progressively developed its capabilities to deliver comprehensive laboratory solutions tailored to specific applications.
Addressing Critical Gaps in Laboratory Procurement
One of the persistent challenges confronting laboratories is maintaining consistency in consumable quality. Variations between manufacturing lots can compromise experimental accuracy, making reliable sourcing essential. Recognising this concern during its initial operations, Igneus introduced third-party quality checks for consumables to minimise inconsistencies and strengthen customer confidence.
Product availability presents another significant challenge, particularly for specialised equipment and consumables sourced from international manufacturers. Traditionally, laboratories often experienced procurement delays extending eight to ten weeks, affecting research schedules and daily operations.
“To address this issue, Igneus has strengthened its inventory management and maintains ready stocks of frequently required products. Its warehouse in Navi Mumbai accommodates a broad selection of laboratory plasticware and consumables serving diagnostic and research applications. This inventory-led approach enables the company to reduce procurement delays and support customers with timely product availability,” says Abhishek Shrotriya, Founder.
Rather than approaching supply as an isolated transaction, Igneus focuses on understanding how product reliability and delivery timelines influence laboratory productivity. This operational perspective has become central to its value proposition.
Delivering Application-Specific Solutions through Technical Expertise
In a competitive laboratory equipment market, Igneus differentiates itself through consultative selling and application-specific product recommendations. Its sales and technical teams engage directly with customers to understand experimental requirements, evaluate product specifications and recommend suitable combinations of instruments and consumables. “The company currently operates with approximately ten field sales professionals who regularly interact with laboratories, conduct technical discussions, prepare quotations and deliver product presentations. Their efforts are supported by dedicated order processing, accounts and marketing teams, enabling coordinated customer engagement,” shares Abhishek Shrotriya. For Igneus, sustained customer trust is built through consistent product quality, technical understanding and dependable service
Igneus also works with established international manufacturers, including Thermo Fisher Scientific and Cole-Parmer, to provide products recognised for their scientific applications. Its portfolio encompasses laboratory equipment, scientific consumables, plasticware and specialised cold storage solutions.
Importantly, the company emphasises optimising laboratory workflows rather than merely increasing product sales. By recommending compatible products and practical configurations, it seeks to help customers control procurement costs while improving operational efficiency.
Customer relationships remain equally important. Positive experiences and word-of-mouth recommendations have contributed to new enquiries, while testimonials shared through professional platforms reinforce market confidence. For Igneus, sustained customer trust is built through consistent product quality, technical understanding and dependable service.
Preparing for the Next Phase of Life Sciences Innovation
As the life sciences industry advances, Igneus anticipates growing demand from emerging therapeutic applications, particularly cell and gene therapy. Abhishek Shrotriya believes that although these treatments are currently concentrated among larger healthcare institutions, their adoption could expand to more hospitals over the next four to five years.
Such developments are expected to increase requirements for specialised consumables, laboratory equipment and temperature-controlled storage infrastructure. Igneus is positioned to address these needs through its existing cold chain portfolio, which includes liquid nitrogen containers, ultra-low-temperature freezers operating at minus 80 degrees Celsius and specialised transport vessels.
“The company also recognises artificial intelligence as an emerging influence on laboratory operations. AI-assisted experimental planning, workflow optimisation and fermentation scale-up are gradually changing how researchers approach process development, creating opportunities for more specialised scientific solutions,” says Abhishek Shrotriya.
Looking ahead, Igneus plans to expand its consumables portfolio with additional plasticware and media designed for cell and gene therapy applications. Simultaneously, it is developing a dedicated healthcare portfolio, with particular emphasis on blood bank equipment.
These priorities reflect a measured expansion strategy centred on evolving laboratory requirements. By strengthening its product offerings while retaining its focus on reliability, availability and technical support, Igneus Life Science aims to remain a dependable partner as India's pharmaceutical and research ecosystem progresses towards increasingly advanced scientific applications.